Dropping back to the previous dose for two to four weeks and then attempting the escalation again often works
In: Caplan LR, Siesjo BK, Weir B, Welch KM, Reis DJ (eds)
Monitoring your progress and making the right call The decision to continue, reduce, or stop GLP-1 therapy should be driven by data, not arbitrary timelines or gut feelings
[19] United States [edit] In the United States, semaglutide is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes, [13] [14] and to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease
not approved for therapeutic use Regulatory Note: WADA prohibited substance (growth hormone secretagogue category) Research Status: Extensively utilized in GH axis, receptor pharmacology, and metabolic studies Availability: BIONIX supplies exclusively for controlled laboratory research Consequently , BIONIX Ipamorelin is intended exclusively for laboratory research applications